title: [Cerebral hemorrhage].
abstract: Intracerebral hemorrhage (ICH) remains a serious condition for which early aggressive care is warranted. Japanese evidence-based stroke guidelines were published in 2015 to present the current and comprehensive recommendations for the diagnosis and treatment of stroke. In the spontaneous ICH, topics focused on prevention, management in the acute and chronic stage, complications, management of coagulopathy and blood pressure, prevention and control of secondary brain injury and intracranial pressure, the role of surgery, and other pathologies of ICH. The management of ICH in pregnancy and the puerperium was newly added. These guidelines provide a framework for goal-directed treatment of the patient with ICH.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nakase
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Motoyama
authors.forename: Shuichi
authors.initials: S
authors.lastname: Yamada
mesh_terms: D000208:Acute Disease; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001932:Brain Neoplasms / Q000150:complications; D020785:Central Nervous System Vascular Malformations / Q000150:complications; D002543:Cerebral Hemorrhage / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D015942:Factor VIIa / Q000008:administration & dosage; D005260:Female; D006392:Hemangioma, Cavernous / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D002538:Intracranial Arteriovenous Malformations / Q000150:complications; D008297:Male; D019060:Minimally Invasive Surgical Procedures; D019635:Neurosurgical Procedures; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications; D011655:Pulmonary Embolism / Q000517:prevention & control; D011994:Recombinant Proteins / Q000008:administration & dosage; D012008:Recurrence; D012121:Respiration, Artificial; D020246:Venous Thrombosis / Q000517:prevention & control
chemical_list: D000959:Antihypertensive Agents; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa